Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May:154:104836.
doi: 10.1016/j.micpath.2021.104836. Epub 2021 Mar 7.

Contribution of STAT3 to the pathogenesis of COVID-19

Affiliations
Review

Contribution of STAT3 to the pathogenesis of COVID-19

Abdollah Jafarzadeh et al. Microb Pathog. 2021 May.

Abstract

Hyper-inflammatory responses, lymphopenia, unbalanced immune responses, cytokine storm, large viral replication and massive cell death play fundamental roles in the pathogenesis of COVID-19. Extreme production of many kinds of pro-inflammatory cytokines and chemokines occur in severe COVID-19 that called cytokine storm. Signal transducer and activator of transcription-3 (STAT-3) present in the cytoplasm in an inactive form and can be stimulated by a vast range of cytokines, chemokines and growth factors. Thus, STAT-3 can participate in the induction of inflammatory responses during coronavirus infections. STAT-3 can also suppress anti-virus interferon response and induce unbalanced anti-virus adaptive immune response, through influencing Th17-, Th1-, Treg-, and B cell-mediated functions. Furthermore, STAT-3 can contribute to the M2 macrophage polarization, lung fibrosis and thrombosis. Moreover, STAT-3 may be directly targeted by some virus-derived protein and operate as a pro-viral or anti-viral element in a virus-specific process. Here, the possible contribution of STAT-3 to the pathogenesis of COVID-19 was explained, while providing potential approaches to target this transcription factor in an attempt for COVID-19 treatment.

Keywords: COVID-19; Immune response; Inflammation; Pathogenesis; SARS-CoV-2; STAT3; Treatment.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper

Figures

Fig. 1
Fig. 1
Activation of STAT-3: Binding of numerous cytokines or growth factors to their specific receptors induces phosphorylation of the receptor-associated JAK1 and then STAT3 is phosphorylated by JAK1. Phosphorylated STAT3 is dimerized and translocated to the nucleus, which causes the expression of target genes contributing to the immunosuppression, inflammation, angiogenesis, proliferation and survival.
Fig. 2
Fig. 2
Contribution of STAT-3-mediated pathways to COVID-19 pathogenesis. Activated STAT-3 can down-regulate lymphopoiesis, E-cadherin expression by vascular endothelial cells, Treg cell activity and anti-viral immune responses (including type I IFN-mediated signaling, NK cells activity, Th1 cell responses and CD8+ CTLs) supporting the lymphopenia, the vascular leak, hyper-inflammation and virus persistence, respectively. Activated STAT-3 can up-regulate the formation of the extracellular matrix, the expression of plasminogen activator inhibitor-1, the polarization and activation of Th17 cells and the polarization of M2 macrophages promoting lung fibrosis, thrombosis, hyper-inflammation/cytokine storm, and virus persistence/lung fibrosis, respectively.

References

    1. Eaaswarkhanth M., Al Madhoun A., Al-Mulla F. Could the D614G substitution in the SARS-CoV-2 spike (S) protein be associated with higher COVID-19 mortality? Int. J. Infect. Dis. 2020;96:459–460. - PMC - PubMed
    1. Tahaghoghi-Hajghorbani S., Zafari P., Masoumi E., Rajabinejad M., Jafari-Shakib R., Hasani B., et al. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res. 2020;290:198197. - PMC - PubMed
    1. Yao X.H., Li T.Y., He Z.C., Ping Y.F., Liu H.W., Yu S.C., et al. [A pathological report of three COVID-19 cases by minimally invasive autopsies] Chin. J. Pathol. 2020;49:E009. - PubMed
    1. Wu J.H., Li X., Huang B., Su H., Li Y., Luo D.J., et al. [Pathological changes of fatal coronavirus disease 2019 (COVID-19) in the lungs: report of 10 cases by postmortem needle autopsy] Chin. J. Pathol. 2020;49:568–575. - PubMed
    1. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506. - PMC - PubMed